Search Results

Pharmacokinetics of Butorphanol and Evaluation of Physiologic and Behavioral Effects after Intravenous and Intramuscular Administration to Neonatal Foals

Authors: Arguedas, M.G.; Hines, M.T.; Papich, M.G.; Farnsworth, K.D.; Sellon, D.C.

Source: Journal of Veterinary Internal Medicine, Volume 22, Number 6, November-December 2008 , pp. 1417-1426(10)

Publisher: Blackwell Publishing

Design and Development of a Novel Robotic Platform for Neuro-Robotics Applications: the NEURobotics ARM (NEURARM)

Authors: Cattin, Emanuele; Roccella, Stefano; Vitiello, Nicola; Sardellitti, Irene; Artemiadis, Panagiotis K.; Vacalebri, Pierpaolo; Vecchi, Fabrizio; Carrozza, Maria Chiara; Kyriakopoulos, Kostas J.; Dario, Paolo

Source: Advanced Robotics, Volume 22, Number 1, 2008 , pp. 3-37(35)

Publisher: VSP, an imprint of Brill

Application of an Entropy-Assisted Optimization Model in Prediction of Agonist and Antagonist Muscle Forces

Authors: Jiang, Zongliang; Mirka, Gary A.

Source: Human Factors and Ergonomics Society Annual Meeting Proceedings, Industrial Ergonomics , pp. 923-927(5)

Publisher: Human Factors and Ergonomics Society

An Efficient Synthesis of Simple β,β '-Cyclobisalkylated Melatoninergic Phenylalkylamides

Authors: Tsotinis, Andrew; Vlachou, Margarita; Papahatjis, Demetris P.; Nikas, Spyros P.; Sugden, David

Source: Letters in Organic Chemistry, Volume 4, Number 2, March 2007 , pp. 92-95(4)

Publisher: Bentham Science Publishers

Does High-Dose Buprenorphine Cause Respiratory Depression?: Possible Mechanisms and Therapeutic Consequences

Authors: Mégarbane, Bruno; Hreiche, Raymond; Pirnay, Stéphane; Marie, Nicolas; Baud, Frédéric J.

Source: Toxicological Reviews, Volume 25, Number 2, 2006 , pp. 79-85(7)

Publisher: Adis International

Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications

Authors: Chabbert-Buffet, Nathalie; Meduri, Geri; Bouchard, Philippe; Spitz, Irving M.

Source: Human Reproduction Update, Volume 11, Number 3, May 2005 , pp. 293-307(15)

Publisher: Oxford University Press

Toll-Like Receptor Signaling: Emerging Opportunities in Human Diseases and Medicine

Authors: Rabindra N. Bhattacharjee; Shizuo Akira

Source: Current Immunology Reviews, Volume 1, Number 1, January 2005 , pp. 81-90(10)

Publisher: Bentham Science Publishers

Coadministration of an Opioid Agonist and Antagonist for Pain Control

Authors: Dima Rozen; Carson Ling; Cris Schade

Source: Pain Practice, Volume 5, Number 1, March 2005 , pp. 11-17(7)

Publisher: Blackwell Publishing

In rats, acute morphine dependence results in antagonist-induced response suppression of intracranial self-stimulation

Authors: Easterling, Keith; Holtzman, Stephen

Source: Psychopharmacology, Volume 175, Number 3, September 2004 , pp. 287-295(9)

Publisher: Springer

Buprenorphine: A Unique Drug with Complex Pharmacology

Authors: Kabirullah Lutfy; Alan Cowan

Source: Current Neuropharmacology, Volume 2, Number 4, October 2004 , pp. 395-402(8)

Publisher: Bentham Science Publishers

Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease

Authors: O'Neill K.; Chen S.; Brinton R.D.

Source: Experimental Neurology, Volume 185, Number 1, January 2004 , pp. 63-80(18)

Publisher: Elsevier

Pharmacologic approaches to sedation, pain relief and neuromuscular blockade in the intensive care unit. part II: Analgesia

Authors: TL Higgins; PG Jodka; A Farid

Source: Clinical Intensive Care, Volume 14, Numbers 3-4, Numbers 3-4/September/December 2003 , pp. 91-98(8)

Publisher: Informa Healthcare

The effects of release height on center of pressure and trunk muscle response following sudden release of stoop lifting tasks

Authors: Chow D.H.K.; Cheng A.C.S.; Holmes A.D.; Evans J.H.

Source: Applied Ergonomics, Volume 34, Number 6, November 2003 , pp. 611-619(9)

Publisher: Elsevier

Absence of nalbuphine anti-analgesia in the rat

Authors: Khasar S.G.; Gear R.W.; Levine J.D.

Source: Neuroscience Letters, Volume 345, Number 3, 24 July 2003 , pp. 165-168(4)

Publisher: Elsevier

CP8668, a novel orally active nonsteroidal progesterone receptor modulator with tetrahydrobenzindolone skeleton

Authors: Tabata Y.; Iizuka Y.; Shinei R.; Kurihara K.-i.; Okonogi T.; Hoshiko S.; Kurata Y.

Source: European Journal of Pharmacology, Volume 461, Number 1, 7 February 2003 , pp. 73-78(6)

Publisher: Elsevier

Agonist-antagonist common drive during fatiguing knee extension efforts using surface electromyography

Authors: Mullany H.; O'Malley M.; St.Clair Gibson A.; Vaughan C.

Source: Journal of Electromyography and Kinesiology, Volume 12, Number 5, October 2002 , pp. 375-384(10)

Publisher: Elsevier

Optimization of a Mixture of an Agonist and an Antagonist of the GABA-Receptor System According to the Safety Criterion

Authors: Sylantyev S.; Zinkovsky V.

Source: Neurophysiology, Volume 34, Numbers 2-3, March 2002 , pp. 243-246(4)

Publisher: Springer

Binding thermodynamics at the human A₃ adenosine receptor

Authors: Merighi S.; Varani K.; Gessi S.; Klotz K.-N.; Leung E.; Baraldi P.G.; Borea P.A.

Source: Biochemical Pharmacology, Volume 63, Number 2, 15 January 2002 , pp. 157-161(5)

Publisher: Elsevier

Antidotal effects of buprenorphine on the behavioral alterations accompanying cocaine and combined cocaine-ethanol toxicity

Authors: Hayase T.; Yamamoto Y.; Yamamoto K.

Source: Pharmacology Biochemistry and Behavior, Volume 71, Number 1, January 2002 , pp. 19-27(9)

Publisher: Elsevier

Changes in electromyographic activity, muscle fibre and force production characteristics during heavy resistance/power strength training in middle-aged and older men and women

Authors: Häkkinen, K.; Kraemer, W. J.; Newton, R. U.; Alen, M.

Source: Acta Physiologica, Volume 171, Number 1, January 2001 , pp. 51-62(12)

Publisher: Blackwell Publishing